Duration: CME/CE Points: Faculty:
30 Minutes
CME : 0.5

Cleveland Clinic Riding the Wave: Clinical Management of Myeloid Malignancies in an Era of Novel Therapies is organized by Cleveland Clinic Foundation Center for Continuing Education and will be held from Jan 17, 2019 - Jan 17, 2021.

Target Audience:
This educational activity is designed for an international audience including medical oncologists/hematologists, clinical and translational researchers, and other physicians and allied health care professionals treating patients with MDS and other bone marrow failure diseases. In addition, members of patient advocacy groups will benefit from this program.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Learning Objective:
• Describe the diagnostic complexities and treatment options for paroxysmal nocturnal hemoglobinuria (PNH).

Additional details will be posted as soon as they are available.

Target Audience



Activity Fee : Fee Details will be updated soon



Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.